Alan Colowick is an accomplished investor and board of directors member with extensive experience in the biotechnology and pharmaceutical industries. They served on the boards of notable organizations such as Harpoon Therapeutics and ReCode Therapeutics, and held leadership roles including Chief Medical Officer at Threshold Pharmaceuticals and CEO at Gloucester Pharmaceuticals. An alumnus of Harvard T.H. Chan School of Public Health, Colowick obtained a Master of Public Health in Decision Sciences and began their medical education at Stanford University School of Medicine. Their strategic insights have been instrumental in guiding several companies through significant acquisitions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices